
Abu Dhabi researchers get the exact same same-day standard as Dubai. Order Tesamorelin before 4 PM Dubai time and it's on that afternoon's dispatch wave, arriving at your Abu Dhabi address the same day. Khalifa City, Yas Island, Saadiyat, Al Reem, Al Raha, Mussafah, Al Maryah — the entire emirate is covered on the same schedule, no zone treated as an afterthought.
Tesamorelin's appeal to Abu Dhabi labs is its documented pharmaceutical history — few research peptides have completed formal Phase 3 clinical trial programmes. That depth of published data is exactly why growth-hormone-axis and metabolic research groups near the Khalifa City medical corridor keep it as a standing order rather than an occasional purchase.
Tesamorelin is a synthetic 44-amino-acid peptide — a stabilised analogue of human growth hormone-releasing hormone (GHRH). It carries a trans-3-hexenoyl modification at the N-terminus that extends its half-life to roughly 26 minutes compared to native GHRH's ~7 minutes, while preserving full receptor agonist activity.
Developed by Theratechnologies and marketed pharmaceutically as Egrifta, Tesamorelin is one of the few GHRH-class peptides to complete a formal clinical trial programme. Falutz J et al. (J Clin Endocrinol Metab. 2010;95(9):4291-4304) reported reductions in visceral adipose tissue across two pooled Phase 3 trials, and follow-up work published in JAMA (Stanley TL et al. 2014;312(4):380-389) documented parallel reductions in liver fat. That published record is what makes it a recurring reference compound in growth-hormone-axis and visceral-fat research.
REVIVE supplies Tesamorelin strictly for laboratory and in-vitro research use — white lyophilized powder, 10 mg per vial (5 mg also available), molecular weight approximately 5135 Da, HPLC-verified purity ≥98.5%. This guide covers logistics and research background only — not administration.
| Emirate / Area | Delivery window | Cut-off time | Cold-chain packaging |
|---|---|---|---|
| Dubai (all zones) | Same-day | 4 PM | Insulated + gel pack |
| Abu Dhabi — Khalifa City | Same-day | 4 PM | Insulated + double gel pack |
| Abu Dhabi — Yas Island | Same-day | 4 PM | Insulated + double gel pack |
| Abu Dhabi — Saadiyat | Same-day | 4 PM | Insulated + double gel pack |
| Abu Dhabi — Al Reem / Al Raha / Mussafah / Al Maryah | Same-day | 4 PM | Insulated + double gel pack |
| Sharjah & Ajman | 24h | 4 PM | Insulated + gel pack |
| Northern Emirates (RAK, Fujairah, UAQ) | 1–2 business days | 4 PM | Reinforced cold-chain |
The route between REVIVE's Dubai hub and Abu Dhabi runs roughly 140 km of highway, and UAE summer heat makes package handling a real variable — ambient temperatures can push well past 45°C. Every Abu Dhabi-bound Tesamorelin vial travels in insulated packaging with double gel packs, even on the same-day run, protecting vial integrity across the corridor without slowing down the delivery promise.
| Spec | Value |
|---|---|
| Vial strength | 10 mg (5 mg also available) |
| Price | AED 629 (5 mg: AED 369) |
| Form | White lyophilized powder |
| Molecular weight | ≈5135 Da |
| Sequence / class | GHRH analogue, 44 amino acids |
| Purity (HPLC) | ≥98.5% |
| Storage (lyophilized) | −20°C, desiccated, protect from light |
| Reconstitution | Bacteriostatic water, 3–5 mL |
Yes — Al Maryah and the surrounding facilities are inside the standard same-day zone with no additional cost.
Yes, co-shipping is standard and consolidates everything into a single insulated delivery — Retatrutide and GHK-Cu are the most common pairings for body-composition research.
Orders confirmed after 4 PM roll to the following dispatch cycle — you'll get next-day delivery rather than same-day, just one cycle later.
A lot-specific HPLC certificate of analysis and research-use-only labelling ship with every Tesamorelin vial.